Clincosm LogoSign in Get a demo

multiple sclerosis, relapsing remitting

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis, Relapsing Remitting Trial (INT131)

Completed
  • Multiple Sclerosis, Relapsing Remitting
  • (no location specified)
Feb 27, 2018

BETAEVAL Global - The New BETACONNECT Auto-injector : Adherence

Completed
  • Multiple Sclerosis, Relapsing Remitting
  • Interferon beta-1b (Betaferon®, BAY 86-5046)
  • BETACONNECT
  • Many locations, Austria
  • +10 more
Nov 5, 2017

Rebif® New Formulation in Real Life Settings (STAR)

Completed
  • Multiple Sclerosis, Relapsing Remitting
  • Rebif® New Formulation
  • Thessaloniki, Greece
    Neurology Clinic, General Hospital of Thessaloniki "G. Papanikol
Jul 30, 2014

Spasticity and Impact on Quality of Life in Multiple Sclerosis

Completed
  • Multiple Sclerosis, Relapsing Remitting
    • Rosario, Argentina
      Fundación Rosarina de Neurorehabilitación
    Oct 13, 2013

    Sexual Dysfunction, Disability and Quality of Life in Multiple

    Completed
    • Multiple Sclerosis, Relapsing Remitting
      • Buenos Aires, Argentina
        Dr. Norma Deri
      Oct 13, 2013

      Differential Immune Effects of Natalizumab

      Completed
      • Multiple Sclerosis, Relapsing Remitting
        • (no location specified)
        Mar 10, 2009